The Venture Codex Logo

The Venture Codex

Overview

Efficient and selective RNA editing platform for protein modification.

Total Raised

$278 M

Rounds

4

Links

Verticals

Biotechnology
Health Care
Pharmaceutical

Investment History

  1. Equity

    Apr 2024

    $70M

  2. Series B

    Jan 2022

    $116M

  3. Series A

    Sep 2020

    $92M

Team

Ram Aiyar

Chief Executive Officer

Andrew Fraley

Founder and Senior Vice President of Technology

Nessan Bermingham

Founder

Todd Chappell

SVP, Strategy and Portfolio Planning